IGF1 and prostate carcinoma: In the future, it is necessary to strengthen multicenter, large-sample prospective studies and the integration of individual-level data, improve covariate adjustment and mechanism exploration, and promote the standardization and clinical translation of IGF-I-related indicators in the field of prostate cancer prevention and control, providing a more solid evidence base for optimizing disease screening strategies and health management.